The Centers for Medicare & Medicaid Services today awarded 20 states American Rescue Plan Act grants to develop and implement mobile crisis intervention services for people experiencing a substance use-related or mental health crisis: Alabama, California, Colorado, Delaware, Kentucky, Massachusetts, Maryland, Maine, Missouri, Montana, North Carolina, New Mexico, Nevada, Oklahoma, Oregon, Pennsylvania, Utah, Vermont, Wisconsin and West Virginia. Beginning next April under the ARPA, state Medicaid programs with a qualified mobile crisis intervention option are eligible for a temporarily enhanced matching rate.

On Friday, CMS awarded five state Medicaid agencies funding to implement demonstrations to increase their capacity to provide substance use disorder treatment and recovery services under the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act: Connecticut, Delaware, Illinois, Nevada, and West Virginia. States participating in the 36-month demonstration will receive enhanced federal reimbursement for increases in Medicaid expenditures for SUD treatment and recovery services.

Related News Articles

Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…
Headline
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…